companies / reprisebio-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-06-14 json
| total_raised | 1,450,0001.4M | ○ |
|---|---|---|
| founded | null | |
| hq | Plymouth, MN | |
| industry | unknown | |
| stage | null |
Early commercial-stage biologics wound-care company with the Miro3D perfusion-decellularized wound matrix.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-05-14 | Funding round | 1,450,0001.4M | null | ○ |
doubleclick floodlight, font awesome, google analytics, google tag manager, http/3, hubspot, jquery migrate 3.4.1, jquery mobile, monsterinsights 10.2.2, mysql, php, site kit 1.180.0
| fact | status | src |
|---|---|---|
| Funding round, $1.4M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-25latest_round: seed, $1.4M, 2026-05-14 → Funding round, $1.4M, 2026-05-14, ○ 2026-06-14 | latest_round | seed, $1.4M, 2026-05-14 → Funding round, $1.4M, 2026-05-14 | ○ 2026-06-14 |
Records begin 2026-09-24. all_changes